Walleye Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-393,125
Closed -$4.7M 5059
2026
Q1
$2.35M Sell
393,125
-1,092,254
-74% -$8.22M 0.01% 1344
2025
Q4
$10.7M Buy
1,485,379
+1,432,903
+2,731% +$11.3M 0.03% 611
2025
Q3
$560K Buy
+52,476
New +$515K ﹤0.01% 2521
2025
Q2
Sell
-23,127
Closed -$239K 4890
2025
Q1
$344K Sell
23,127
-52,309
-69% -$804K ﹤0.01% 2851
2024
Q4
$1.13M Buy
75,436
+2,829
+4% +$46.1K ﹤0.01% 2284
2024
Q3
$1.39M Buy
72,607
+5,714
+9% +$118K ﹤0.01% 2313
2024
Q2
$1.38M Buy
+66,893
New +$1.33M ﹤0.01% 2499
2024
Q1
Sell
-72,551
Closed -$1.25M 5755
2023
Q4
$1.05M Buy
72,551
+22,743
+46% +$309K ﹤0.01% 2302
2023
Q3
$865K Buy
49,808
+11,068
+29% +$231K ﹤0.01% 2363
2023
Q2
$806K Buy
38,740
+15,230
+65% +$331K ﹤0.01% 2033
2023
Q1
$553K Buy
+23,510
New +$631K 0.01% 1625

Other funds holding OGN

Walleye Capital's OGN Position: Q2 2026 in Review

Walleye Capital sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 393,125 shares — an estimated $4.7M sold.

Walleye Capital first reported a position in OGN in Q1 2023 and held it in 11 quarters. The position peaked at $10.7M in Q4 2025. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Walleye Capital reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 393,125 Organon & Co shares in Q2 2026, an estimated $4.7M.
  • Walleye Capital first reported a position in Organon & Co in Q1 2023 and held it in 11 quarters.
  • Walleye Capital's Organon & Co position peaked at $10.7M in Q4 2025.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.